Oral Protein / Peptide-based Drugs: Addressing Key Unmet Needs Across Disease Indications

Orally administrable protein / peptide-based therapeutics offer several advantages including, effective treatment of numerous clinical conditions and degenerative disorders. Interestingly, recent advances in this domain have led to the development of several treatment strategies that, according to developers, exhibit the necessary capabilities to overcome challenges posed by traditional oral protein formulations  and peptide-based therapies. One of the key objectives behind the aforementioned developments is to overcome issues related to high costs associated with the design and production of such pharmacological interventions. However, it is important to highlight that there are still several challenges which need to be addressed in order to develop biologic drugs capable of effectively being administered via the oral route without undergoing significant losses in specificity and / or bioavailability. Over 40 oral drug delivery technologies have been designed so far. Owing to the numerous advantages of oral drug delivery, including ease of administration, minimal pain and risk of drug reaction, and self-administration, we are led to believe that the oral protein / peptide therapeutics market is anticipated to witness a significant growth in the coming future.

Pipeline Overview of Oral Peptide and Protein-based Therapeutics

With four commercialized therapies and over 120 clinical / preclinical development programs, oral protein and peptide therapies represent a lucrative segment of the pharmaceutical industry.

Pipeline Overview of Oral Peptide and Protein-based Therapeutics
Oral Protein / Peptide-based Drugs

Clinical Research Landscape of Oral Peptide and Protein-based Therapeutics

Over 200 clinical trials focused on oral protein and peptides have been registered across the globe; majority of these trials are evaluating therapies intended for chronic constipation, diabetes and irritable bowel syndrome.

Clinical Research Landscape of Oral Peptide and Protein-based Therapeutics
Oral Protein / Peptide-based Drugs

Oral Drug Development and Formulation Technologies are being Leveraged by Companies to Develop Novel Therapeutic Interventions

More than 40 innovative technology platforms are presently being leveraged by industry stakeholders for the development of oral proteins and peptides.

Oral Drug Development and Formulation Technologies are being Leveraged by Companies to Develop Novel Therapeutic Interventions
Oral Protein / Peptide-based Drugs

Intellectual Property Landscape of Orally Administrable Protein / Peptide-based Therapeutics

Over 300 patents have been granted / filed by academia and industry stakeholders in the last five years, exclusively for oral protein and peptides and associated delivery technologies.

Intellectual Property Landscape of Orally Administrable Protein / Peptide-based Therapeutics
Oral Protein / Peptide-based Drugs

The Oral Protein and Peptides Market is anticipated to grow at a CAGR of over 20%, during 2022-2032

Owing to the established potential of marketed drugs and anticipated approval of novel therapies the market opportunity associated with oral protein and peptide therapies is anticipated to witness an annualized growth of over 20% in the coming decade.

The Oral Protein and Peptides Market is anticipated to grow at a CAGR of over 20%, during 2022-2032
Oral Protein / Peptide-based Drugs

To get a detailed information on the drug pipeline, key opinion leaders, drug delivery technologies, market landscape, funding and investment trend, partnerships and collaborations, clinical trials activity, patent landscape, big pharma activity, key commercialization strategies adopted by companies and the likely market evolution kindly visit the link below

For further information on this domain, check out the report –

Oral Proteins and Peptides Market (4th Edition)

You may also be interested in the following titles:

  1. Live Biotherapeutic Products and Microbiome Manufacturing Market
  2. Next Generation Complement Therapeutics Market
  3. Intranasal Therapeutics and Drug Delivery Systems Market 

Our Social Media Platform

Web: https://www.rootsanalysis.com/

LinkedIn: https://in.linkedin.com/company/roots-analysis

Twitter: https://twitter.com/RootsAnalysis.com